found similar rates for kidney failure, death and severe infections between patients treated with RTX or CYC [15] in a large retrospective observational study of 600 AAV patients with almost 70% showing renal involvement and a clear MPO preponderance. The gene discussed is MPO; the disease is kidney failure.